Evidence map›Paper›PMID 32115520›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy.

Tomokazu Minakata, Yoshio Nakano, Shinobu Tamura, Yamanishi Kazuki, Kana Hayakawa, Takahiro Hayakawa, Takayuki Oota, Tokuzou Fuzimoto, Yukiko Yamano, Takemasa Takii

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tomokazu MinakataDepartment of Nephrology, Kinan Hospital, Japan.
Yoshio NakanoDepartment of Internal Medicine, Kinan Hospital, Japan.
Shinobu TamuraDivision of Hematology, Department of Internal Medicine, Wakayama Medical University, Japan.
Yamanishi KazukiDepartment of Internal Medicine, Kinan Hospital, Japan.
Kana HayakawaDepartment of Internal Medicine, Kinan Hospital, Japan.
Takahiro HayakawaDepartment of Internal Medicine, Kinan Hospital, Japan.
Takayuki OotaDepartment of Internal Medicine, Kinan Hospital, Japan.
Tokuzou FuzimotoDepartment of Internal Medicine, Kinan Hospital, Japan.
Yukiko YamanoDepartment of Nephrology, Kinan Hospital, Japan.
Takemasa TakiiDepartment of Mycobacteriology, The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Japan.
Kinan Hospital · JPJapan Anti Tuberculosis Association · JPWakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 74-year-old man underwent intravesical bacillus Calmette-Guerin (BCG) therapy for bladder cancer and later presented with lower left back pain. Magnetic resonance imaging of the spine showed high signal intensity, diagnosed as a cystic lesion in the epidural and bilateral intestinal psoas muscle. A computed tomography-guided needle biopsy and histological examination revealed bacteria from the family Mycobacteriaceae, and Mycobacterium bovis was identified using multiplex polymerase chain reaction. If lower back pain appears in a patient who has undergone BCG therapy, it is necessary to test for tuberculous spondylitis. In addition, QuantiFERON is useful for the differential diagnosis of M. bovis BCG infection.

Indexed as

Adjuvants, ImmunologicAdministration, IntravesicalAgedAntineoplastic Agents, ImmunologicalBCG VaccineHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleMycobacterium bovisSpondylitisTomography, X-Ray ComputedTuberculosis, SpinalUrinary Bladder NeoplasmsAdjuvants, ImmunologicAntineoplastic Agents, ImmunologicalBCG Vaccinebacillus Calmette-GuerinMycobacterium bovistuberculous spondylitis

Identifiers

PMID32115520
PMCPMC7086334
OpenAlexW3006705614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.